Related references
Note: Only part of the references are listed.Understanding the relationships between environmental factors and exacerbations of COPD
Alicia Gayle et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)
Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long-acting bronchodilator-naive COPD patients: A pooled analysis
Shigeo Muro et al.
RESPIROLOGY (2020)
Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis
Xiaona Jia et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
Hesperetin-5,7,3′-O-Trimethylether Dually Inhibits Phosphodiesterase 3/4 and Methacholine-Induced Airway Hyperresponsiveness in Sensitized and Challenged Mice
Chung-Hung Shih et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Implementation of a pharmacist-led transitional care clinic
Sara N. Layman et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
Thierry Buclin et al.
FRONTIERS IN PHARMACOLOGY (2020)
Sustained adherence to ESC guideline-recommended medications is associated with lower long-term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort
Sarah Bitar et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)
Association of Healthy Lifestyle With Years Lived Without Major Chronic Diseases
Solja T. Nyberg et al.
JAMA INTERNAL MEDICINE (2020)
Influencing Factors and Exercise Intervention of Cognitive Impairment in Elderly Patients with Chronic Obstructive Pulmonary Disease
Ting Wang et al.
CLINICAL INTERVENTIONS IN AGING (2020)
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naive to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials
Roland Buhl et al.
ADVANCES IN THERAPY (2020)
Recent Advances in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Stacey-Ann Whittaker Brown et al.
MEDICAL CLINICS OF NORTH AMERICA (2020)
Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease
Rajesh Kunadharaju et al.
CLINICS IN CHEST MEDICINE (2020)
Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations
Francesco Vasques et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Home Oxygen Therapy for Adults with Chronic Lung Disease An Official American Thoracic Society Clinical Practice Guideline
Susan S. Jacobs et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Gender does not impact the short- or long-term outcomes of home-based pulmonary rehabilitation in patients with COPD
Jean-Marie Grosbois et al.
ERJ OPEN RESEARCH (2020)
Progress in the mechanism and targeted drug therapy for COPD
Cuixue Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Lost in Transition: Pharmacist Roles in Identifying and Evaluating Medication-Related Problems During Hospital Discharge Follow-up Visits in a Primary Care Setting
Alexis Dellogono et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2020)
Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction
Tafadzwa F. Mtisi et al.
CARDIOLOGY IN REVIEW (2020)
Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India
Suhaj Abdulsalim et al.
PHARMACOECONOMICS-OPEN (2020)
Tiotropium in chronic obstructive pulmonary disease - a review of clinical development
Antonio Anzueto et al.
RESPIRATORY RESEARCH (2020)
Trends in burden of chronic obstructive pulmonary disease in Iran, 1995-2015: findings from the global burden of disease study
Seyed Yaser Hashemi et al.
ARCHIVES OF PUBLIC HEALTH (2020)
Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE) A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial
Kristina Vermeersch et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Efficacy and safety profile of roflumilast in a real-world experience
Aykut Cilli et al.
JOURNAL OF THORACIC DISEASE (2019)
Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Jie Yang et al.
CANADIAN RESPIRATORY JOURNAL (2019)
Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam
Tu-Son Nguyen et al.
RESPIRATORY MEDICINE (2019)
A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens
Hu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Therapeutic potential of BLT1 antagonist for COPD: involvement of inducing autophagy and ameliorating inflammation
Li Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease
Anneloes L. van Rijn et al.
PLOS ONE (2019)
New Perspectives in Oxygen Therapy Titration: Is Automatic Titration the Future?
Sagrario Mayoralas-Alises et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2019)
Evaluation of the protective effects of β-blockers in the management of acute exacerbations of chronic obstructive pulmonary disease
Cameron D. Thomas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Chronic obstructive pulmonary disease and the early stage of cor pulmonale: A perspective in treatment with pulmonary arterial hypertension-approved drugs
Seiichiro Sakao
RESPIRATORY INVESTIGATION (2019)
Bacterial and Viral Identification Rate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea
Juwhan Choi et al.
YONSEI MEDICAL JOURNAL (2019)
Pharmacist-Driven Spirometry Screening to Target High-Risk Patients in a Primary Care Setting
Jangus B. Whitner et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2019)
Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial
Ana Juanes et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2018)
Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
De-Shun Liu et al.
CHINESE MEDICAL JOURNAL (2018)
The pharmacological treatment of chronic comorbidities in COPD: mind the gap!
Umberto Vespasiani-Gentilucci et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
Effects of Tiotropium Combined with Theophylline on Stable COPD Patients of Group B, D and its Impact on Small Airway Function: A Randomized Controlled Trial
Xiao-feng Xiong et al.
ADVANCES IN THERAPY (2018)
Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
Mohamed Ismail Abdul Aziz et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study
Suhaj Abdulsalim et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2018)
Optimizing identification and management of COPD patients - reviewing the role of the community pharmacist
Thys van der Molen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The Correlation of Serum Brain Natriuretic Peptide and Interleukin-6 with Quality of Life Using the Chronic Obstructive Pulmonary Disease Assessment Test
Hassan Ghobadi et al.
MEDICAL PRINCIPLES AND PRACTICE (2017)
Worldwide prevalence of viral infection in AECOPD patients: A meta-analysis
Habib Jafarinejad et al.
MICROBIAL PATHOGENESIS (2017)
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease
Y. Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
Syed Mohammad Tariq et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis
Mario Cazzola et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine
Marco Contoli et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report
Claus F. Vogelmeier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Impact of Pharmaceutical Care Interventions on Health-Related Quality-of-Life Outcomes: A Systematic Review and Meta-analysis
Mohammed A. Mohammed et al.
ANNALS OF PHARMACOTHERAPY (2016)
Short-term versus longer duration of glucocorticoid therapy for exacerbations of chronic obstructive pulmonary disease
Zhao Ma et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial
Erin Davis et al.
TRIALS (2016)
The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study
Chuanwei Xin et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis
David A. Scott et al.
BMC PULMONARY MEDICINE (2015)
Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin
A. Safarika et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Allison A. Lambert et al.
PLOS ONE (2015)
Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells
Mutsuo Yamaya et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease ( PHARMACOP): a randomized controlled trial
Eline Tommelein et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Pharmaceutical care for patients with COPD in Belgium and views on protocol implementation
Eline Tommelein et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2014)
Outgrowth of the Bacterial Airway Microbiome after Rhinovirus Exacerbation of Chronic Obstructive Pulmonary Disease
Philip L. Molyneaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease
Carl Llor et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The role of bronchodilator treatment in the prevention of exacerbations of COPD
Jadwiga A. Wedzicha et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary disease
Jun Zhang et al.
RESPIROLOGY (2012)
Impact of pharmaceutical care on health outcomes in patients with COPD
Anan S. Jarab et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2012)
Ciprofloxacin-induced theophylline toxicity: a population-based study
Tony Antoniou et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients
Andrea Haemmerlein et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2011)
Systemic manifestations and comorbidities of COPD
P. J. Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease
Dali Shukla et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients
Guilan Xiong et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Pulmonary hypertension in COPD
A. Chaouat et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia
J Saas-Torres et al.
RESPIRATORY MEDICINE (2003)